Suppr超能文献

尼古丁依赖无烟烟草法格斯特龙测试（FTND-ST）。

The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).

作者信息

Ebbert Jon O, Patten Christi A, Schroeder Darrell R

机构信息

Nicotine Research Program, Primary Care Internal Medicine, Department of Internal Medicine, Mayo Clinic; 200 1st Street Southwest, Rochester, MN 55905, USA.

出版信息

Addict Behav. 2006 Sep;31(9):1716-21. doi: 10.1016/j.addbeh.2005.12.015. Epub 2006 Jan 31.

DOI:10.1016/j.addbeh.2005.12.015
PMID:16448783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1618870/
Abstract

Few nicotine dependence measures have been developed for smokeless tobacco (ST) users. Existing measures are limited by the requirement to rate the nicotine content of ST brands for which data is scarce or non-existent. We modified the Fagerström Test for Nicotine Dependence (FTND) for ST users, referred to this scale as the FTND-ST, and evaluated its characteristics in a population of 42 ST users. The correlation between the FTND-ST total score and the serum cotinine concentrations was 0.53 (p<0.001). Internal consistency reliability assessed using the coefficient alpha was 0.47. Correlations and the coefficient alpha are similar to those reported for commonly used nicotine dependence measures. Development and refinement of nicotine dependence measures for ST users are essential steps in order to advance the field of ST research.

摘要

针对无烟烟草（ST）使用者开发的尼古丁依赖测量方法很少。现有测量方法受到以下要求的限制：即需要对ST品牌的尼古丁含量进行评分，而相关数据稀缺或不存在。我们对ST使用者的尼古丁依赖程度弗格斯特罗姆测试（FTND）进行了修改，将该量表称为FTND-ST，并在42名ST使用者群体中评估了其特性。FTND-ST总分与血清可替宁浓度之间的相关性为0.53（p<0.001）。使用α系数评估的内部一致性信度为0.47。相关性和α系数与常用尼古丁依赖测量方法所报告的相似。为ST使用者开发和完善尼古丁依赖测量方法是推进ST研究领域的重要步骤。

相似文献

1
The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).
Addict Behav. 2006 Sep;31(9):1716-21. doi: 10.1016/j.addbeh.2005.12.015. Epub 2006 Jan 31.
2
A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence.
Addict Behav. 2014 Mar;39(3):622-9. doi: 10.1016/j.addbeh.2013.11.016. Epub 2013 Nov 27.
3
Psychometric Properties of Fagerström Test for Nicotine Dependence for Smokeless Tobacco Users (FTND-ST).
Nicotine Tob Res. 2017 Sep 1;19(9):1095-1101. doi: 10.1093/ntr/ntx076.
4
Evaluating the role of smokeless tobacco use indices as brief measures of dependence.
Addict Behav. 2017 Jun;69:87-92. doi: 10.1016/j.addbeh.2017.02.019. Epub 2017 Feb 10.
5
Evaluation of tobacco dependence measures in South Asian smokeless tobacco users.
Drug Alcohol Depend. 2019 Oct 1;203:66-71. doi: 10.1016/j.drugalcdep.2019.05.034. Epub 2019 Jul 30.
6
A review of the validity and reliability of smokeless tobacco dependence measures.
Addict Behav. 2012 Apr;37(4):361-6. doi: 10.1016/j.addbeh.2011.12.003. Epub 2011 Dec 20.
7
Evaluating the Psychometric Properties of the Severson 7-Item Smokeless Tobacco Dependence Scale (SSTDS).
Nicotine Tob Res. 2021 Jun 8;23(7):1224-1229. doi: 10.1093/ntr/ntaa269.
8
Measuring nicotine dependence among smokeless tobacco users.
Addict Behav. 2006 Sep;31(9):1511-21. doi: 10.1016/j.addbeh.2005.11.005. Epub 2006 Jan 4.
9
Assessment of the Tobacco Dependence Screener Among Smokeless Tobacco Users.
Nicotine Tob Res. 2016 May;18(5):885-91. doi: 10.1093/ntr/ntv283. Epub 2015 Dec 30.
10
Measuring dependence in smokeless tobacco users.
Addict Behav. 1995 Jul-Aug;20(4):443-50. doi: 10.1016/0306-4603(95)00013-3.

引用本文的文献

1
Unveiling tobacco struggle in rural areas: field insights and experiences from Rajasthan, India.
Front Public Health. 2025 Aug 11;13:1615242. doi: 10.3389/fpubh.2025.1615242. eCollection 2025.
2
Prevalence and predictors of chronic disease among rural and medically underserved populations using smokeless tobacco.
Front Public Health. 2025 May 9;13:1565910. doi: 10.3389/fpubh.2025.1565910. eCollection 2025.
3
Interventions for smokeless tobacco use cessation.
Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD015314. doi: 10.1002/14651858.CD015314.pub2.
4
Lower Successful Quit Rate of Menthol Tobacco Users in a Tobacco Cessation Program: An Explanatory Analysis in Search of Potential Mechanisms.
Glob J Cardiovasc Dis. 2025;4(1):70-78. doi: 10.31586/gjcd.2025.1279. Epub 2025 Feb 26.
5
CEASE Tobacco Cessation Program: Validation of Self-Rated Quit with Fagerstrom Test for Nicotine Dependence.
Glob J Cardiovasc Dis. 2025;4(1):22-33. doi: 10.31586/gjcd.2025.1190. Epub 2025 Feb 7.
6
Efficacy of shared decision making in tobacco cessation among health facilities of Haryana, India - A double blinded, parallel group Randomized Controlled trial Protocol.
Public Health Pract (Oxf). 2024 Dec 22;9:100581. doi: 10.1016/j.puhip.2024.100581. eCollection 2025 Jun.
7
Patterns and Correlates of Multiple tobacco Product use Among people With HIV in India.
Tob Use Insights. 2024 Dec 9;17:1179173X241303587. doi: 10.1177/1179173X241303587. eCollection 2024.
8
Post-discharge tobacco abstinence in a Mumbai hospital after implementation of tobacco cessation counseling: A pragmatic evaluation of the LifeFirst program.
PLoS One. 2024 Nov 12;19(11):e0312319. doi: 10.1371/journal.pone.0312319. eCollection 2024.
9
Assessment of the effect of premedication on the success of inferior alveolar nerve block in tobacco chewing patients with symptomatic irreversible pulpitis: a randomized control trial.
J Dent Anesth Pain Med. 2024 Oct;24(5):351-360. doi: 10.17245/jdapm.2024.24.5.351. Epub 2024 Sep 26.
10
Evaluation of the Smokeless Tobacco Awareness, Attitude, and Response Knowledge (STAARK) Scale With Integrated Risk Assessment for Tailored Intervention.
Cureus. 2024 Oct 3;16(10):e70744. doi: 10.7759/cureus.70744. eCollection 2024 Oct.

本文引用的文献

1
A survey of characteristics of smokeless tobacco users in a treatment program.
Am J Health Behav. 2005 Jan-Feb;29(1):25-35. doi: 10.5993/ajhb.29.1.3.
2
Residential treatment for smokeless tobacco use: a case series.
J Subst Abuse Treat. 2004 Jun;26(4):261-7. doi: 10.1016/j.jsat.2004.01.008.
3
Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.
Addict Behav. 2004 Feb;29(2):349-55. doi: 10.1016/j.addbeh.2003.08.046.
4
Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
Nicotine Tob Res. 2003 Dec;5(6):885-9. doi: 10.1080/14622200310001614647.
5
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.
Clin Chem. 2002 Sep;48(9):1460-71.
6
Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
MMWR Morb Mortal Wkly Rep. 1999 May 21;48(19):398-401.
7
Measuring dependence in smokeless tobacco users.
Addict Behav. 1995 Jul-Aug;20(4):443-50. doi: 10.1016/0306-4603(95)00013-3.
8
Some methodological cautions in the use of the Tolerance Questionnaire.
Addict Behav. 1986;11(4):439-42. doi: 10.1016/0306-4603(86)90024-9.
9
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.
N Engl J Med. 1988 Nov 17;319(20):1318-30. doi: 10.1056/NEJM198811173192005.
10
Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day.
Br J Addict. 1989 Jul;84(7):791-9. doi: 10.1111/j.1360-0443.1989.tb03059.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验